Alzheimer's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with Alzheimer's disease according to the NIA-AA standard diagnostic guidelines.
- People whose dementia has been rated as mild to moderate or less, based on a standard clinical assessment scale called the Clinical Dementia Rating Scale (a score of 2 points or lower).
- People who are experiencing at least one behavioural or psychological symptom (such as mood or behaviour changes), as measured by a standard assessment tool called the Neuropsychiatric Inventory (NPI), with a frequency multiplied by severity score of at least 1.
- People who are willing and able to sign a consent form agreeing to take part in the trial.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have reasons why acupuncture treatment would not be safe for them, such as a tendency to bleed easily at needle sites or an allergy to metal.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Baohui Jia, Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Phone: 010-88001454
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Neuropsychiatric Inventory (NPI); Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change (ADCS-CGIC)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.